Ovarian Cancer (updated of QLQ-OV28)
Project summary
Ovarian cancer accounts for 6% of all female cancer deaths and is the cause of more deaths in women than all other gynaecological malignancies combined. Measuring QoL to evaluate the treatment options of different types of cancer are crucial. Since the development of EORTC QLQ OV28 in 1997 not only more treatment options for ovarian cancer are available but also other side-effects are reported. Therefore, an updated questionnaire will be developed.
Achievements
Literature-review was performed from
which studies using the existing
questionnaire can be identified as well as
new questionnaires with issues that are
not included in the existing ones.
Activation of collaborating sites
Development of the issue-list
Current status:
Formulation of issues , check the issues with working groups ( DOG and QoL)
Future plans
Interviews with the patients and HCP, preparing the amendment for phase 2
For patients
When evaluating the impact of an illness such as cancer, one of the most important areas to consider is the effect on quality of life. In this study, a literature review and interviews with patients and health care professionals are conducted to help us understand the impact of ovarian cancer on the quality of life of patients. Due to the rising number of new treatments, the question is whether the existing questionnaire to assess the quality of life specific to patients diagnosed with ovarian cancer should be updated.